Oligonucleotide cdmo capabilities include but are not limited to:

DNA Oligos
UNA and TINA oligonucleotides
Light-activated oligonucleotides
Chimeric oligonucleotides
Various modified or unmodified antisense oligonucleotides
Polypeptide-Nucleotide Conjugates
RNA Oligos

Chimeric oligonucleotides
Long RNA synthesis
CRISPR guide strand (sgRNA) synthesis
siRNA and UsiRNA
microRNA
Nano self-assembled RNA drugs